Serial Number 88904727
Registration 7507876
700

Registration Progress

Application Filed
May 7, 2020
Under Examination
Nov 30, 2021
Approved for Publication
Oct 5, 2021
Published for Opposition
Oct 5, 2021
Registered
Sep 17, 2024

Trademark Image

Basic Information

Serial Number
88904727
Registration Number
7507876
Filing Date
May 7, 2020
Registration Date
September 17, 2024
Published for Opposition
October 5, 2021
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 17, 2024
Registration
Registered
Classes
005 042

Rights Holder

Entrada Therapeutics, Inc.

03
Address
One Design Center Pl, Suite 17-500
Boston, MA 02210

Ownership History

Entrada Therapeutics, Inc.

Original Applicant
03
Boston, MA

Entrada Therapeutics, Inc.

Owner at Publication
03
Boston, MA

Entrada Therapeutics, Inc.

Original Registrant
03
Boston, MA

Legal Representation

Attorney
Stephanie H. Bald

USPTO Deadlines

Next Deadline
1695 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240917)
Due Date
September 17, 2030
Grace Period Ends
March 17, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description Documents
Sep 17, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 17, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 13, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Aug 13, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jul 10, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 29, 2024 IUAF S USE AMENDMENT FILED Loading...
May 29, 2024 IUAF S USE AMENDMENT FILED Loading...
May 29, 2024 IUAF S USE AMENDMENT FILED Loading...
Jul 7, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 30, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 29, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
May 29, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
May 29, 2024 EXT5 S SOU EXTENSION 5 FILED Loading...
May 29, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 9, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 7, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 7, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 7, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 24, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 24, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 24, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 24, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jul 24, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 20, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 18, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 18, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 18, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 26, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 24, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 24, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 24, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 16, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 14, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 14, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 14, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 30, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 5, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 5, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 15, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 28, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 20, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 19, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 19, 2021 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
May 21, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 21, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 21, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 24, 2021 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Feb 24, 2021 GNFR O FINAL REFUSAL E-MAILED Loading...
Feb 24, 2021 CNFR R FINAL REFUSAL WRITTEN Loading...
Feb 7, 2021 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...

Detailed Classifications

Class 005
House mark for a full line of pharmaceuticals; pharmaceuticals for human use, namely, pharmaceuticals for treatment and prevention of pain and allergic, inflammatory, oncological, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, hepatic, and nephrological diseases and conditions mediated via intracellular transport processes
First Use Anywhere: Jun 14, 2022
First Use in Commerce: Jun 14, 2022
Class 042
Pharmaceutical research and development services
First Use Anywhere: 20230200
First Use in Commerce: 20230200

Additional Information

Design Mark
The mark consists of a design of five curved lines. The center of each line meets at the right side of the design, and the lines fan out to the left both above and below the center, forming an overall shape that resembles a curved arrow pointing to the right. The lines increase in width from left to right.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 042